Embecta (EMBC) Cash from Operations Growth (1y) (2021 - 2026)
Embecta (EMBC) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 56.79% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 428.92% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -39.59% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -4.24% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -30.53% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 90.02% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 186.74% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 210.36% |
| 10 | Embecta | 183.23 Mn | -10.17 Mn | 127.80 Mn | -2.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.20% |
| Dec 31, 2025 | 424.53% |
| Sep 30, 2025 | 215.79% |
| Jun 30, 2025 | 3,966.67% |
| Mar 31, 2025 | 30.86% |
| Dec 31, 2024 | 59.54% |
| Sep 30, 2024 | -10.14% |
| Jun 30, 2024 | 77.42% |
| Mar 31, 2024 | 286.92% |
| Dec 31, 2023 | -121.69% |
| Sep 30, 2023 | -48.97% |
| Jun 30, 2023 | -128.35% |
| Mar 31, 2023 | -107.12% |
| Dec 31, 2022 | -56.48% |
| Sep 30, 2022 | -32.16% |
| Jun 30, 2022 | -74.71% |
| Mar 31, 2022 | 52.55% |
| Dec 31, 2021 | 14.33% |